TA
COLL icon

Teton Advisors’s Collegium Pharmaceutical COLL Stock Holding History

Teton Advisors’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-19,900
Closed -$348K – 384
2020
Q2 		$348K Sell
19,900
-2,000
-9% -$39.2K 0.06% 309
2020
Q1 		$358K Hold
21,900
– – 0.06% 307
2019
Q4 		$451K Sell
21,900
-21,500
-50% -$358K 0.05% 347
2019
Q3 		$498K Sell
43,400
-4,000
-8% -$45.7K 0.05% 333
2019
Q2 		$623K Sell
47,400
-500
-1% -$6.69K 0.06% 292
2019
Q1 		$725K Hold
47,900
– – 0.07% 263
2018
Q4 		$822K Buy
47,900
+26,700
+126% +$457K 0.09% 242
2018
Q3 		$312K Sell
21,200
-10,800
-34% -$191K 0.03% 392
2018
Q2 		$763K Hold
32,000
– – 0.07% 272
2018
Q1 		$818K Hold
32,000
– – 0.08% 257
2017
Q4 		$591K Buy
32,000
+5,000
+19% +$71.6K 0.05% 290
2017
Q3 		$283K Buy
+27,000
New +$298K 0.03% 363

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Teton Advisors's COLL Position: Q3 2020 in Review

Teton Advisors sold out of Collegium Pharmaceutical (COLL) in Q3 2020, closing a stake of 19,900 shares — an estimated $348K sold.

Teton Advisors first reported a position in COLL in Q3 2017 and held it in 12 quarters. The position peaked at $822K in Q4 2018. 140 funds tracked by Wall St. Rank hold COLL as of Q3 2020.

  • Teton Advisors reported no remaining Collegium Pharmaceutical position as of Q3 2020 after selling out during the quarter.
  • Teton Advisors sold 19,900 Collegium Pharmaceutical shares in Q3 2020, an estimated $348K.
  • Teton Advisors first reported a position in Collegium Pharmaceutical in Q3 2017 and held it in 12 quarters.
  • Teton Advisors's Collegium Pharmaceutical position peaked at $822K in Q4 2018.
  • 140 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2020.

Based on Teton Advisors's 13F filing for Q3 2020, filed 6 Nov 2020.